NASDAQ: LSTA
Lisata Therapeutics Inc Stock Ownership - Who owns Lisata Therapeutics?

Insider buying vs selling

Have Lisata Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kristen K. BuckEVP RD and CMO2026-01-092,982$1.97
$5.87kSell
Kristen K. BuckEVP RD and CMO2026-01-092,982$1.97
$5.87kSell
Kristen K. BuckEVP RD and CMO2026-01-093,221$1.97
$6.35kSell
Kristen K. BuckEVP RD and CMO2026-01-092,147$1.97
$4.23kSell
Tariq ImamSVP Bus Dev General Counsel2026-01-091,401$1.97
$2.76kSell
Tariq ImamSVP Bus Dev General Counsel2026-01-09840$1.97
$1.65kSell
Tariq ImamSVP Bus Dev General Counsel2026-01-09747$1.97
$1.47kSell
Tariq ImamSVP Bus Dev General Counsel2026-01-09513$1.97
$1.01kSell
David J. MazzoPresident CEO2026-01-0910,503$1.97
$20.69kSell
David J. MazzoPresident CEO2026-01-0910,515$1.97
$20.71kSell

1 of 2

LSTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LSTA insiders and whales buy or sell their stock.

LSTA Shareholders

What type of owners hold Lisata Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rimasia Capital Partners Manager Ltd279.26%24,632,862$114.05MInsider
Jr Family Trust Aholt140.04%12,352,227$57.19MInsider
Robert Joseph Aholt Jr.132.10%11,652,230$53.95MInsider
Caribbean Stem Cell Group Inc70.86%6,250,000$28.94MInsider
Eric Wei51.59%4,550,499$21.07MInsider
Enhance Biomedical Holdings Ltd45.35%4,000,000$18.52MInsider
Mingsheng Shi43.37%3,825,770$17.71MInsider
Jian M. Zhang43.37%3,825,770$17.71MInsider
Fullbright Finance Ltd34.55%3,047,432$14.11MInsider
Wayne A. Marasco30.46%2,686,713$12.44MInsider

1 of 3

LSTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LSTA0.84%99.16%Net SellingNet Selling
PDSB11.47%24.13%Net Buying
VERU6.39%93.61%Net Buying
JSPR29.25%70.75%Net Buying
CYPH20.33%79.67%Net SellingNet Selling

Lisata Therapeutics Stock Ownership FAQ

Who owns Lisata Therapeutics?

Lisata Therapeutics (NASDAQ: LSTA) is owned by 8.38% institutional shareholders, 994.21% Lisata Therapeutics insiders, and 0.00% retail investors. Rimasia Capital Partners Manager Ltd is the largest individual Lisata Therapeutics shareholder, owning 24.63M shares representing 279.26% of the company. Rimasia Capital Partners Manager Ltd's Lisata Therapeutics shares are currently valued at $114.05M.

If you're new to stock investing, here's how to buy Lisata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.